Open Access Leucaemia Journals
Leukaemia could be a
cancer that starts in blood-forming tissue, typically the bone marrow. It ends up in the over-production of abnormal white blood cells, the a part of the system that defends the body against infection. Blood
cells square measure fashioned within the bone marrow, the spongy tissue found within the bones. Blood-forming stem
cells divide to supply either additional stem
cells or immature
cells that become mature blood
cells over time. A blood vegetative cell could become a myeloid vegetative cell or a humour vegetative cell.
A myeloid vegetative cell becomes one among 3 kinds of mature blood cells:
• Red blood
cells that carry gas to all or any
tissues of the body.
• Platelets that kind blood clots to prevent haemorrhage.
• Granulocytes (white blood cells) that fight
infection and unwellness.
A humour vegetative cell becomes a lymphocyte cell and so one among 3 kinds of lymphocytes (white blood cells):
• B lymphocytes that create antibodies to assist fight infection.
• T lymphocytes that facilitate B lymphocytes create the antibodies that facilitate fight infection.
• Natural killer
cells that attack
cancer cells and viruses.
Leukaemia affects white blood
cells and may be classified by the kind of WBC affected (myeloid or lymphatic) and by the approach the unwellness progresses (acute or chronic). Acute and chronic don't check with however serious the unwellness is however to however speedily it progresses.
High Impact List of Articles
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Insulin degludec in Type 1 diabetes
VS Eligar,S Bain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Insulin degludec in Type 1 diabetes
VS Eligar,S Bain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Assessment and management of mucositis in head and neck cancer patients
Marcelo Bonomi, Nadia Camille, Krzysztof Misiukiewicz, Asma Latif, Vishal Gupta, Seth Blacksburg, Eric Genden,Marshall Posner
Review: Clinical Trail Outcomes: Clinical Investigation
-
Assessment and management of mucositis in head and neck cancer patients
Marcelo Bonomi, Nadia Camille, Krzysztof Misiukiewicz, Asma Latif, Vishal Gupta, Seth Blacksburg, Eric Genden,Marshall Posner
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Personalized medicine in colorectal cancer: the evidence so far
Avinash Gupta, Wasir Saka, David J Kerr
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in colorectal cancer: the evidence so far
Avinash Gupta, Wasir Saka, David J Kerr
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
Relevant Topics in Clinical